Veraxa Biotech Holding AG(VRXA)

盘后2.71-0.05-1.81%19:59 EDT

2.76-0.27-8.91%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
Veraxa Biotech Holding AG
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.veraxa.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Veraxa Biotech AG于2025年6月25日在瑞士法律下注册成立。该公司是一家专注于肿瘤学的生物技术公司，拥有急性髓系白血病的临床项目，以及用于开发抗体药物偶联物和T细胞衔接器的专有平台技术。其目标是建立一个肿瘤学项目管线，旨在为患者实现疗效的同时最大限度地减少副作用。
- 06-16
  年度报告
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 02-14
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 02-13
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2025-11-28
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2025-09-30
  企业合并公告
  Form 425 - Prospectuses and communications, business combinations
  Form 425 - Prospectuses and communications, business combinations
- 2025-09-30
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence

分时
5日
日
周
月

数据加载中...

最高

3.49

今开

3.13

量比

0.68

最低

2.65

昨收

3.03

换手率

1.17%

热议股票

{"pagemeta":{"title":"Veraxa Biotech Holding AG(VRXA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Veraxa Biotech Holding AG(VRXA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Veraxa Biotech Holding AG,VRXA,Veraxa Biotech Holding AG股票,Veraxa Biotech Holding AG股票老虎,Veraxa Biotech Holding AG股票老虎国际,Veraxa Biotech Holding AG行情,Veraxa Biotech Holding AG股票行情,Veraxa Biotech Holding AG股价,Veraxa Biotech Holding AG股市,Veraxa Biotech Holding AG股票价格,Veraxa Biotech Holding AG股票交易,Veraxa Biotech Holding AG股票购买,Veraxa Biotech Holding AG股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Veraxa Biotech Holding AG(VRXA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Veraxa Biotech Holding AG(VRXA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"summary","symbol":"VRXA","data":{"stockData":{"symbol":"VRXA","market":"US","secType":"STK","nameCN":"Veraxa Biotech Holding AG","latestPrice":2.76,"timestamp":1783540800000,"preClose":3.03,"halted":0,"volume":1856387,"hourTrading":{"tag":"盘后","latestPrice":2.71,"preClose":2.76,"latestTime":"19:59 EDT","volume":27665,"amount":76883.0429,"timestamp":1783555168691,"change":-0.05,"changeRate":-0.018116,"amplitude":0.105072},"delay":0,"changeRate":-0.08910891089108912,"floatShares":158000000,"shares":164000000,"eps":0.2142,"marketStatus":"未开盘","change":-0.27,"latestTime":"07-08 16:00:00 EDT","open":3.13,"high":3.49,"low":2.65,"amount":5742486.285029001,"amplitude":0.277228,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.2142,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1783584000000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":3.03,"preHourTrading":{"tag":"盘前","latestPrice":3.06,"preClose":3.03,"latestTime":"09:29 EDT","volume":100762,"amount":313957.4035268,"timestamp":1783517398996,"change":0.03,"changeRate":0.009901,"amplitude":0.125413},"postHourTrading":{"tag":"盘后","latestPrice":2.71,"preClose":2.76,"latestTime":"19:59 EDT","volume":27665,"amount":76883.0429,"timestamp":1783555168691,"change":-0.05,"changeRate":-0.018116,"amplitude":0.105072},"volumeRatio":0.681877},"tweetData":null,"newsData":null,"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"21402223","market":"us","labels":[],"media":"sec.gov","original_id":"AN182912626006546-VRXA","pdf_url":"","pub_time":1781582400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","symbol":"VRXA","title":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","titleType":"年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/2079109/000182912626006546/0001829126-26-006546-index.htm","us_notice_code":"Form 20-F","us_title_en":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"20-F","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2079109/000182912626006546/veraxabiotech_20f.htm","primary":true,"translateUrl":"","linkName":"veraxabiotech_20f.htm","type":"20-F","id":"NTFILEizqu2hBnbdH5v4y2","market":"us","size":1501637},{"description":"EXHIBIT 1.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2079109/000182912626006546/veraxabiotech_ex1-1.htm","primary":false,"translateUrl":"","linkName":"veraxabiotech_ex1-1.htm","type":"EX-1.1","id":"NTFILE2XjWCiizYtaXgCiw","market":"us","size":344243},{"description":"EXHIBIT 2.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2079109/000182912626006546/veraxabiotech_ex2-1.htm","primary":false,"translateUrl":"","linkName":"veraxabiotech_ex2-1.htm","type":"EX-2.1","id":"NTFILE9mJxaA5sfwQmf9sA","market":"us","size":54633},{"description":"EXHIBIT 2.5","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2079109/000182912626006546/veraxabiotech_ex2-5.htm","primary":false,"translateUrl":"","linkName":"veraxabiotech_ex2-5.htm","type":"EX-2.5","id":"NTFILEHWw73wg98ip39pDN","market":"us","size":64976},{"description":"EXHIBIT 4.7","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2079109/000182912626006546/veraxabiotech_ex4-7.htm","primary":false,"translateUrl":"","linkName":"veraxabiotech_ex4-7.htm","type":"EX-4.7","id":"NTFILE78RuGrYbey5b1wm2","market":"us","size":15162},{"description":"EXHIBIT 4.11","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2079109/000182912626006546/veraxabiotech_ex4-11.htm","primary":false,"translateUrl":"","linkName":"veraxabiotech_ex4-11.htm","type":"EX-4.11","id":"NTFILE5KEXC2hwxUQQyLUn","market":"us","size":296314},{"description":"EXHIBIT 4.12","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2079109/000182912626006546/veraxabiotech_ex4-12.htm","primary":false,"translateUrl":"","linkName":"veraxabiotech_ex4-12.htm","type":"EX-4.12","id":"NTFILE4thNkvspkzczGxq4","market":"us","size":142870},{"description":"EXHIBIT 8.1","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2079109/000182912626006546/veraxabiotech_ex8-1.htm","primary":false,"translateUrl":"","linkName":"veraxabiotech_ex8-1.htm","type":"EX-8.1","id":"NTFILEDeJGQJANQUtxzPCp","market":"us","size":2844},{"description":"EXHIBIT 12.1","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2079109/000182912626006546/veraxabiotech_ex12-1.htm","primary":false,"translateUrl":"","linkName":"veraxabiotech_ex12-1.htm","type":"EX-12.1","id":"NTFILE5V17LqKLfURDZAYo","market":"us","size":12428},{"description":"EXHIBIT 12.2","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2079109/000182912626006546/veraxabiotech_ex12-2.htm","primary":false,"translateUrl":"","linkName":"veraxabiotech_ex12-2.htm","type":"EX-12.2","id":"NTFILEFvG6hETh19tr1915","market":"us","size":13245},{"description":"EXHIBIT 13.1","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2079109/000182912626006546/veraxabiotech_ex13-1.htm","primary":false,"translateUrl":"","linkName":"veraxabiotech_ex13-1.htm","type":"EX-13.1","id":"NTFILE9NXNiDq1JV8hGRx6","market":"us","size":7841},{"description":"EXHIBIT 13.2","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2079109/000182912626006546/veraxabiotech_ex13-2.htm","primary":false,"translateUrl":"","linkName":"veraxabiotech_ex13-2.htm","type":"EX-13.2","id":"NTFILE49eY8zQPunwJAZDN","market":"us","size":7697},{"description":"EXHIBIT 15.1","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2079109/000182912626006546/veraxabiotech_ex15-1.htm","primary":false,"translateUrl":"","linkName":"veraxabiotech_ex15-1.htm","type":"EX-15.1","id":"NTFILE7BRB1eKDHdTT6KWm","market":"us","size":219836},{"description":"EXHIBIT 15.2","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2079109/000182912626006546/veraxabiotech_ex15-2.htm","primary":false,"translateUrl":"","linkName":"veraxabiotech_ex15-2.htm","type":"EX-15.2","id":"NTFILE2rkBtdwhoZBgsmpQ","market":"us","size":2129},{"description":"EXHIBIT 15.3","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2079109/000182912626006546/veraxabiotech_ex15-3.htm","primary":false,"translateUrl":"","linkName":"veraxabiotech_ex15-3.htm","type":"EX-15.3","id":"NTFILEFCBJRcNZMe3oaeDm","market":"us","size":3854},{"description":"EXHIBIT 15.4","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2079109/000182912626006546/veraxabiotech_ex15-4.htm","primary":false,"translateUrl":"","linkName":"veraxabiotech_ex15-4.htm","type":"EX-15.4","id":"NTFILENv7NRZKvsEetEwLK","market":"us","size":3874},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2079109/000182912626006546/ex1-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex1-1_001.jpg","type":"GRAPHIC","id":"NTFILE8RaAiCTmkeEsGU4q","market":"us","size":46207}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"年度报告","pubTime":"2026-06-16 12:00","pubTimestamp":1781582400,"title_zh":"Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":false,"id":"21325286","market":"us","labels":[],"media":"sec.gov","original_id":"AN182912626001328-VRXA","pdf_url":"","pub_time":1771013671000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"VRXA","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2079109/0001829126-26-001328-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2026-02-14 04:14","pubTimestamp":1771013671,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21325307","market":"us","labels":[],"media":"sec.gov","original_id":"AN182912626001296-VRXA","pdf_url":"","pub_time":1770940943000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"VRXA","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2079109/0001829126-26-001296-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2079109/000182912626001296/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE8vRYE3Qo5ck92rcj","market":"us","size":22281},{"description":"GRAPHIC","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2079109/000182912626001296/corresp_001.jpg","primary":false,"translateUrl":"","linkName":"corresp_001.jpg","type":"GRAPHIC","id":"NTFILE4NWh9fsFhyaNFjZK","market":"us","size":5663}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2026-02-13 08:02","pubTimestamp":1770940943,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21325287","market":"us","labels":[],"media":"sec.gov","original_id":"AN182912625009493-VRXA","pdf_url":"","pub_time":1764327780000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"VRXA","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2079109/0001829126-25-009493-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2079109/000182912625009493/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE7QoGQ2EFxhosbbQ7","market":"us","size":31704},{"description":"GRAPHIC","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2079109/000182912625009493/corresp_001.jpg","primary":false,"translateUrl":"","linkName":"corresp_001.jpg","type":"GRAPHIC","id":"NTFILE5rBBDTo9xbutJaSJ","market":"us","size":3658}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2025-11-28 19:03","pubTimestamp":1764327780,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20228647","market":"us","labels":[],"media":"sec.gov","original_id":"AN182912625007783-VRXA","pdf_url":"","pub_time":1759204800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 425 - Prospectuses and communications, business combinations","symbol":"VRXA","title":"Form 425 - Prospectuses and communications, business combinations","titleType":"企业合并公告","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2079109/000182912625007783/0001829126-25-007783-index.htm","us_notice_code":"Form 425","us_title_en":"Form 425 - Prospectuses and communications, business combinations","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"425","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2006815/000182912625007783/voyageracq_425.htm","primary":true,"translateUrl":"","linkName":"voyageracq_425.htm","type":"425","id":"NTFILEGGuMhZw8TcQAZK3j","market":"us","size":30477},{"description":"GRAPHIC","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2006815/000182912625007783/img_001.jpg","primary":false,"translateUrl":"","linkName":"img_001.jpg","type":"GRAPHIC","id":"NTFILEBY3sVnhHFneEE3DZ","market":"us","size":103136},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2006815/000182912625007783/img_002.jpg","primary":false,"translateUrl":"","linkName":"img_002.jpg","type":"GRAPHIC","id":"NTFILEBGSrATjEgGJn5CKC","market":"us","size":934}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"Business Combinations","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"企业合并公告","pubTime":"2025-09-30 12:00","pubTimestamp":1759204800,"title_zh":"Form 425 - Prospectuses and communications, business combinations","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21325272","market":"us","labels":[],"media":"sec.gov","original_id":"AN182912625007726-VRXA","pdf_url":"","pub_time":1759179366000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"VRXA","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2079109/0001829126-25-007726-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2079109/000182912625007726/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE2jZiqaViwSPNaAvi","market":"us","size":140918},{"description":"GRAPHIC","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2079109/000182912625007726/corresp_001.jpg","primary":false,"translateUrl":"","linkName":"corresp_001.jpg","type":"GRAPHIC","id":"NTFILE8ypekg6X3Kmezghk","market":"us","size":4918}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2025-09-30 04:56","pubTimestamp":1759179366,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":true},"companyData":{"profile":{"websiteUrl":"http://www.veraxa.com","stockEarnings":[{"period":"1week","weight":0.6},{"period":"1month","weight":-0.852},{"period":"ytd","weight":-0.852}],"compareEarnings":[{"period":"1week","weight":-0.0005},{"period":"1month","weight":0.0084},{"period":"3month","weight":0.0963},{"period":"6month","weight":0.074},{"period":"1year","weight":0.2016},{"period":"ytd","weight":0.0931}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Veraxa Biotech AG于2025年6月25日在瑞士法律下注册成立。该公司是一家专注于肿瘤学的生物技术公司，拥有急性髓系白血病的临床项目，以及用于开发抗体药物偶联物和T细胞衔接器的专有平台技术。其目标是建立一个肿瘤学项目管线，旨在为患者实现疗效的同时最大限度地减少副作用。","exchange":"NASDAQ","name":"Veraxa Biotech Holding AG","nameEN":"Veraxa Biotech Holding AG"},"aProfile":null}}}